NASDAQ:CGEN - Nasdaq - IL0010852080 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 27.59M | 27.86M | 33.46M | 7.50M | 6.00M | |||
Cost Of Goods | 8.23M | 7.93M | 2.00M | 980.00K | 680.00K | |||
Gross Profit | 19.36M | 19.93M | 31.45M | 6.53M | 5.32M | |||
Operating Expenses | 34.16M | 34.83M | 44.45M | 41.89M | 40.39M | |||
Research and Development | 24.17M | 24.81M | 34.47M | 30.65M | 28.69M | |||
Selling, General, and Administrative Expenses | 9.98M | 10.02M | 9.97M | 11.25M | 11.70M | |||
Operating Income | -14.79M | -14.89M | -12.99M | -35.37M | -35.07M | |||
Interest Income/Expense | 5.20M | 3.47M | 2.96M | 1.78M | 890.00K | |||
Other Income/Expense | N/A | 1.71M | 250.00K | -30.00K | -30.00K | |||
Income Before Taxes | -9.60M | -9.71M | -9.78M | -33.64M | -34.20M | |||
Income Tax | 4.55M | 4.52M | 8.97M | 60.00K | 0.00 | |||
Net Income | -14.14M | -14.23M | -18.75M | -33.69M | -34.20M | |||
EBITDA | N/A | -14.40M | -12.52M | -34.89M | -34.61M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.16 | -0.16 | -0.21 | -0.39 | -0.41 | |||
Non GAAP EPS | -0.16 | -0.16 | -0.22 | -0.40 | -0.40 | |||
Statistics | ||||||||
Gross Profit Margin | 70.18% | 71.54% | 94.01% | 87.07% | 88.67% | |||
Profit Margin | -51.27% | -51.07% | -56.05% | -449.20% | -570.00% | |||
Operating Profit Margin | -53.62% | -53.44% | -38.83% | -471.60% | -584.50% |
All data in USD